How Biotech Commercialization Models Are Evolving
Biotech commercialization models are evolving in response to regulatory complexity, capital market discipline, and payer scrutiny in the United States. The traditional linear pathway from discovery to approval to sales force build out has given way to integrated, capital-efficient strategies that align clinical development with reimbursement and market access planning from the outset. In 2026, … Read more